期刊文献+

特立帕肽对大鼠药物相关性颌骨坏死模型作用的实验研究

Experimental study of the effect of teriparatide on a medication-related rat model of osteonecrosis of the jaw
下载PDF
导出
摘要 目的:建立稳定的药物相关性颌骨坏死(medication-related osteonecrosis of the jaw,MRONJ)模型,探究特立帕肽对MRONJ的治疗作用。方法:选择10月龄SD大鼠,经尾静脉注射唑来膦酸(80μg/kg),每周1次,持续7周,第8周拔除右上颌第一、第二磨牙。拔牙术后8周,观察大鼠颌骨坏死情况。将颌骨坏死建模成功的动物随机分为对照组和实验组,分别接受生理盐水和特立帕肽(60μg/kg,每周3次)皮下注射治疗,4周后处死大鼠,进行大体观察、组织学检测、micro-CT检测,评价特立帕肽对MRONJ的治疗效果。结果:对照组大鼠颌骨坏死未见愈合,且坏死程度加重;micro-CT影像见颌骨纹理紊乱,边缘粗糙,死骨形成,骨破坏区与鼻旁窦相通。实验组见大鼠拔牙创逐渐缩小,67%的大鼠拔牙创完全愈合;micro-CT影像见拔牙创内新骨形成,牙槽骨愈合征象。结论:特立帕肽对大鼠MRONJ具有显著的治疗作用。 Objective:To establish a stable model of medication-related osteonecrosis of the jaw(MRONJ),and to explore the therapeutic effect of teriparatide on MRONJ.Methods:10-month-old SD rats were selected and injected with zoledronic acid(80μg/kg)via tail vein once a week for 7 weeks;the first and second molars of the right maxillary were extracted in the 8th week.Eight weeks after tooth extraction,the rat jaw osteonecrosis was observed.The animals with successful modeling of osteonecrosis of the jaw were randomly divided into the control group and the experimental group,and received subcutaneous injection of saline and teriparatide(60μg/kg,3 times a week),respectively.The animals were sacrificed 4 weeks later.Histology and micro-CT analysis were performed to evaluate the therapeutic effect of teriparatide on MRONJ.Results:In the control group,the rat jaw osteonecrosis did not heal,and the degree of necrosis was aggravated.Micro-CT images showed disordered jaw texture,rough margins,and sequestrum formation.The bone destruction area communicated with the paranasal sinus.In the experimental group,the extraction wounds were gradually reduced,and 67% of the extraction wounds in the rats were completely healed;micro-CT images showed new bone formation in the extraction wound and the signs of alveolar bone healing.Conclusion:Teriparatide has a significant therapeutic effect on MRONJ in rats.
作者 廖晨羽 徐陆晨 李运峰 LIAO Chenyu;XU Luchen;LI Yunfeng(State Key Laboratory of Oral Diseases,National Clinical Research Center for Oral Diseases,Department of Orthognathic and Joint Surgery,West China Hospital of Stomatology,Sichuan University,Chengdu 610041;Department of Oral and Maxillofacial Surgery,Stomatological Hospital and Dental School of Tongji University,Shanghai Engineering Research Center of Tooth Restoration and Regeneration,Shanghai 200072,China)
出处 《口腔颌面外科杂志》 CAS 2024年第1期29-33,共5页 Journal of Oral and Maxillofacial Surgery
基金 四川省自然科学基金项目(2023NSFSC0570) 成都市科技局技术创新研发项目(2022-YF05-01838-SN)。
关键词 药物相关性颌骨坏死 治疗 唑来膦酸 动物模型 特立帕肽 medication-related osteonecrosis of the jaw treatment zoledronic acid animal model teriparatide
  • 相关文献

参考文献6

二级参考文献84

  • 1孙明霞,赵玉亮,林蓉燕,王晓云,金瑢.帕米膦酸二钠治疗骨转移癌致上颌骨坏死一例[J].中国肿瘤临床与康复,2006,13(2). 被引量:3
  • 2胡静,邹淑娟,李昌龙,张晓冬.白细胞介素──1刺激新生小鼠骨吸收培养液中PGE_2含量的测定[J].临床口腔医学杂志,1997,13(1):27-28. 被引量:2
  • 3张庆鸿,梁星,刘梦桃,朱保民,付俊.流体剪切力作用强度对极化破骨细胞ATP6V1a1 mRNA的影响[J].华西口腔医学杂志,2007,25(4):396-398. 被引量:9
  • 4Ruggiero 51. Bisphosphonate -related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci, 2011, 1218: 38-46.
  • 5Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med, 2005, 353 (1 ) :99 -102; discussion 199-102.
  • 6Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol, 2005, 23(34):8580-8587.
  • 7Woo SB, Hellstein JW, Kalmar JR. Narrative[corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med, 2006, 144(10): 753-761.
  • 8Ruggiero SL, Dodson TB, Assael LA, et aL American association of oral and maxillofacial surgeons position paper on bisphosphonate -related osteonecrosis of the jaws. J Oral Maxillofac Surg , 2007, 65(3): 369-376.
  • 9Mavrokokki T, Cheng A, Stein B, et al. Nature and frequency of bisphosphonate -associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg, 2007, 65(3): 415-423.
  • 10Felsenberg D. Osteonecrosis of the jaw-a potential adverse effect of bisphosphonate treatment. Nat Clin Pract Endocrinol Metab, 2006, 2( 12): 662-663.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部